Hydreight Technologies Inc. announces the closure of the life offer of $ 5.4 million

Not for distribution to Wire Wire services of the United States or For dissemination in the United States

Vancouver, British Columbia, February 26, 2025 (Globe Newswire) – Hydreight Technologies Inc. (TSXV: Nurs) (“Hydreight“Or”Company“), a mobile clinical network of nurses, doctors and pharmacy of North America, fully integrated, is pleased to announce that, more to the company’s news statements dated February 10, 2025 and February 18, 2025, it has closed its private placement of commercially reasonable “better reasonable efforts” with Beacon Securities Limited (the “Agent“) Acting as the only agent. The company issued 3,492,300 units of the company (each, to”Unit“) at a price of $ 1.55 per unit for gross income added $ 5,413,065 (El”Offering“). The offer was made in accordance with an agency agreement dated February 26, 2025, between the company and the agent (the”Agency Agreement“).

Shane Madden, the company’s executive director, commented that “the company greatly appreciates market support and is very happy to see a demand for institutional investors so strong in the offer, which has exceeded the initial expectations of management. We continue to focus .

The terms of the offer consisted of the sale of up to 2,581,000 units, subject to an agent option to increase the number of units offered by up to 3,710,000 additional units (the “Agent option“). The agent’s option was exercised for a total of 911,300 additional units. The units were issued in accordance with the financing exemption of the listed issuer (El”Financing Exemption of the Listing Issuer“) Under part 5 of the national instrument 45-106 – Prospect exemptions (“Ni 45-106“).

Each unit consists of a common participation in the capital of the company (each, to “Share the unit“) and an order to buy common shares (each, to”Order“) of the company. The Warrants were issued in accordance with a court order dated February 26, 2025, between the company and Odyssey Trust Company as a court order and each order gives the holder to acquire a participation to acquire a participation Common company (each, a “Shared aspart“) At a price of $ 2.00 per judicial order for a period of 36 months from the closing date of the offer.

As a consideration to act as an agent, the agent received (i) an cash commission of $ 257,823.90, (ii) a corporate finance rate of $ 70,297.50 and (III) 209,538 non -transferable compensation options (Las “Compensation options“), Exercised for a period of 24 months after the closing date to acquire, together, that number of common shares in the capital of the company (“Compensation option actions“) At an exercise price equal to $ 1.55 per action of compensation option.

The values ​​issued under the exemption of financing of the quoted issuer, including the actions of the unit and any judicial order, are not subject to a period of waiting in accordance with the applicable Canadian securities laws.

The company intends to use the net income collected from the offer to support the growth of sales and for working capital and general corporate purposes as described more in the company’s offer document under the exemption of financing of financing from Issuers quoted dated February 10, 2025.

The values ​​mentioned in this document have not been, and have not been registered in the United States 1933 Securities Law (he “US Law. UU.“), Or any law of state values ​​of the United States, and cannot be offered or sold in the United States or for, or for the account or benefit of any person in the United States or anyone within the United States , the absence registration or the exemptions of the registration requirements of the US Law of Securities and the applicable laws of state values ​​of the United States. offer to buy values In the United States, there will be no sale of these values ​​in any jurisdiction in which said offer, request or sale would be illegal. Regulations of the United States Securities Law.

Neither TSX Venture Exchange nor its regulation services provider (as that term is defined in the Policies of the Risk Exchange TSX) accepts the responsibility for the adequacy or precision of this release.

About Hydreight Technologies Inc.

Hydreight Technologies Inc. is building one of the largest mobile clinical networks in the United States. Its patented and fully integrated platform houses a network of more than 2500 nurses, more than 100 doctors and a pharmacy network in 50 states. The platform includes an incorporated and easy -to -use set of fully integrated tools for accounting, documentation, sales, inventory, reserve and management of patient data, which allows licensed health professionals to provide services directly to patients in the Home, office or hotel. Hydreight is closing the gap between compliance with the supplier and patient’s comfort, the empowerment of nurses, Med Spa technicians and other licensed health professionals. The Hydreight platform allows health professionals to provide services independently, in their own terms or add mobile services to existing operations based on the location. Hydreight has a 503b pharmacy network that serves 50 states and is closely affiliated with an electronic suppliers and telemedicine suppliers certified by the US.

WARNING DECLARATION regarding prospective statements

Certain statements made and information contained in this press release, including statements on the use of the income raised under the offer, is “prospective information” in the sense of applicable Canadian securities legislation. All statements, apart from the statements of historical facts, are prospective statements. “anticipates”, “believes” or variations of such words, or statements that certain actions, events or results can “,” could “,” would “,” could “be taken”, “occur” or “achieved” . Grades of the offer, are subject to a variety of risks and uncertainties that could cause real events or results to differ from those reflected in the prospective statements, including, among others, with respect to the offer and issuance of the units, including The conditions of the financial markets, the economic conditions that include government regulations with respect to them, including rates, protective government regulations, Consumer responses to such actions and other related effects, the discretion of management regarding the use of income and the use of available funds after completing the offer, including the moment and cost of planned corporate projects and developments and the use of funds in relation to them, and the other risk factors described in our presentations of available values ​​at www.sedarplus .California. Prospective statements or prospective information are related to future events and future performance and include statements on the expectations and beliefs of management based on information currently available for the company.

Although the company believes that the assumptions and factors used in the preparation of these future -looking statements are reasonable based on the information currently available for management at the date of the present, the results and real developments may differ materially from those contemplated Due to these statements and no guarantee can be given that such events will occur in the times revealed or at all. Readers are warned that the previous list of factors is not exhaustive. Therefore, readers are noticed that they do not deposit an undue dependence on prospective statements and future information. Any prospective statement only speaks to the date of this press release and, except what can be required by the applicable securities laws, the company renounces any intention or obligation to update any prospective information, either as a result of new information, changing circumstances or otherwise.

For further information, please contact:

Shane Madden

Director and Boss Executive Official

Hydreight Technologies Inc.

Email: (protected email)

Telephone: (480) 790 6886